[Cross resistance of a new platinum analogue, ACT-078, to CDDP and CBDCA]

MLA

T, Misawa, et al. “[Cross Resistance of a New Platinum Analogue, ACT-078, to CDDP and CBDCA].” Gan to Kagaku Ryoho. Cancerchemotherapy, vol. 22, no. 4, Mar. 1995. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........fc7917e5cc3fff52c2bf10a0a612648b&authtype=sso&custid=ns315887.

APA

T, M., K, H., C, K., O, M., N, H., F, K., & Y, T. (1995). [Cross resistance of a new platinum analogue, ACT-078, to CDDP and CBDCA]. Gan to Kagaku Ryoho. Cancerchemotherapy, 22(4).

Chicago

T, Misawa, Higashide K, Konda C, Maeda O, Hasegawa N, Kikkawa F, and Tomoda Y. 1995. “[Cross Resistance of a New Platinum Analogue, ACT-078, to CDDP and CBDCA].” Gan to Kagaku Ryoho. Cancerchemotherapy 22 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........fc7917e5cc3fff52c2bf10a0a612648b&authtype=sso&custid=ns315887.